Convertible

Ault Alliance, Inc. Announces Adjournment of Its Annual Meeting of Stockholders

Retrieved on: 
Friday, December 29, 2023

Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced the adjournment of the Company’s 2023 Annual Meeting of Stockholders (the “Meeting”), which was scheduled to be held at 9:00 a.m. (Pacific Time) on December 29, 2023 but has been postponed due to the absence of quorum to conduct business.

Key Points: 
  • Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced the adjournment of the Company’s 2023 Annual Meeting of Stockholders (the “Meeting”), which was scheduled to be held at 9:00 a.m. (Pacific Time) on December 29, 2023 but has been postponed due to the absence of quorum to conduct business.
  • To access the virtual meeting please click the Virtual Shareholder Meeting link: http://www.meetnow.global/MXV24TS .
  • Further information regarding this change to the location, time and date of the Meeting can be found in the Notice of Change of Location, Time and Date of Annual Meeting of Stockholders filed by the Company with the Securities and Exchange Commission on December 29, 2023.
  • If you did not vote at all with respect to any such proposal, we urge you to vote your shares in favor of all the proposals.

Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas

Retrieved on: 
Thursday, December 28, 2023

Given this market potential, vast amounts of time and capital that have been invested to find an effective treatment for GA.

Key Points: 
  • Given this market potential, vast amounts of time and capital that have been invested to find an effective treatment for GA.
  • Earlier this year the FDA approved the first medicine for the treatment of GA, SYFOVRE®1 (pegcetacoplan injection) from Apellis.
  • In August of this year, a second product was approved for GA, IZERVAY™2(avacincaptad pegol intravitreal solution) from Iveric Bio, an Astellas company, with a similar profile to SYFOVE.
  • In the event the total Working Capital costs would amount to the total remaining amount under the Atlas funding program, i.e.

Nine Mile Metals Completes Convertible Loan Financing

Retrieved on: 
Friday, December 15, 2023

VANCOUVER, British Columbia, Dec. 15, 2023 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it has closed its convertible loan financing for a total of $201,000 (the “Loans”).

Key Points: 
  • VANCOUVER, British Columbia, Dec. 15, 2023 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it has closed its convertible loan financing for a total of $201,000 (the “Loans”).
  • The Convertible Loans have a term of 12 months from the closing (the “Maturity Date”) and bear interest at 15 per cent per annum, calculated and payable on the Maturity Date.
  • Convertible Loan proceeds will be used for advancing the bulk sample program on the Nine Mile Brook project and general working capital.
  • $10,400 in cash and 104,000 Warrants were received by Research Capital Corporation as a Finder’s Fee for the Convertible Loan.

Vertex, Inc. Announces Offer to Acquire E-Invoicing Leader Pagero

Retrieved on: 
Wednesday, December 13, 2023

KING of PRUSSIA, Pa., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX), a global provider of indirect tax solutions, today announced that it has commenced a public tender offer for 100% of the shares of Pagero Group AB (publ) (“Pagero”) at a price of 36 SEK in cash per share, equivalent to a total tender value of approximately $555 million1.

Key Points: 
  • “Vertex and Pagero have a shared vision to accelerate global commerce and help companies automate and digitize their compliance operations,” noted Vertex CEO David DeStefano.
  • This press release shall not constitute an offer to buy or a solicitation of an offer to sell any Pagero securities.
  • The full details of the offer, including complete instructions on how to tender Pagero shares, will be included in the offer document.
  • Vertex will host a conference call at 8:30 AM ET / 2:30 PM CET today, December 13, 2023, to discuss the Pagero tender offer.

BCNN TEKUMO ANNOUNCES RECORD Q4 PROGRESS REPORT

Retrieved on: 
Monday, December 11, 2023

NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Balincan USA Inc. ("Balincan" or the "Company") and Tekumo announces a record progress update for Q4, 2023.

Key Points: 
  • NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Balincan USA Inc. ("Balincan" or the "Company") and Tekumo announces a record progress update for Q4, 2023.
  • “This reflects our continued success with Tekumo as an industry leading service delivery platform.
  • It enables product and service companies to manage onsite installation and maintenance of technology systems and devices using On-Demand local technicians.
  • The Company has filed for a name and symbol change to Tekumo, Inc., TKMO, subject to FINRA approval.

Nine Mile Metals Announces Further Updates to Convertible Loan Financing

Retrieved on: 
Tuesday, December 5, 2023

VANCOUVER, British Columbia, Dec. 04, 2023 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it will amend the proposed unsecured convertible loan financing that it announced in the Company’s news releases on November 21 and 27, 2023, (the “Convertible Loan”).

Key Points: 
  • VANCOUVER, British Columbia, Dec. 04, 2023 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it will amend the proposed unsecured convertible loan financing that it announced in the Company’s news releases on November 21 and 27, 2023, (the “Convertible Loan”).
  • Convertible Loan proceeds will be used for advancing the bulk sample program on the Nine Mile Brook project and general working capital.
  • The updates to the Convertible Loan financing are that proceeds will be up to $250,000 and it will be the choice of each lender whether to convert the amount owing on the Maturity Date into Units.
  • The terms of the Convertible Loan are subject to acceptance by the CSE.

Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes

Retrieved on: 
Monday, December 4, 2023

Merit also intends to grant the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $82.5 million aggregate principal amount of the notes.

Key Points: 
  • Merit also intends to grant the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $82.5 million aggregate principal amount of the notes.
  • The notes will be senior unsecured obligations of Merit and will accrue interest payable semiannually in arrears.
  • The interest rate, initial conversion rate and other terms of the notes will be determined at the time of pricing of the offering.
  • The capped call transactions will cover, subject to anti-dilution adjustments, the number of shares of Merit’s common stock initially underlying the notes.

Applied Optoelectronics Announces Proposed Private Offering of $80 Million of Convertible Senior Notes due 2026

Retrieved on: 
Thursday, November 30, 2023

Final terms for the offering of the Notes will be determined at the time of pricing.

Key Points: 
  • Final terms for the offering of the Notes will be determined at the time of pricing.
  • The Notes will be convertible at the option of holders of the Notes under certain specified circumstances, as set forth in the indenture governing the Notes.
  • Initially, the Notes will not be guaranteed, but the Notes will be fully and unconditionally guaranteed, on a senior, unsecured basis, by certain of our future domestic subsidiaries.
  • Following the completion of the offering, we may engage in additional exchanges, or we may repurchase or induce conversions, of the 2024 notes.

Nine Mile Metals Updates Loan Financing to Convertible Loan

Retrieved on: 
Monday, November 27, 2023

VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it will update the proposed unsecured loan financing for proceeds of up to $500,000 that it announced in the Company’s news release on November 21, 2023, to an unsecured convertible loan financing (the “Convertible Loan”).

Key Points: 
  • VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it will update the proposed unsecured loan financing for proceeds of up to $500,000 that it announced in the Company’s news release on November 21, 2023, to an unsecured convertible loan financing (the “Convertible Loan”).
  • The Convertible Loan financing will be for proceeds of up to $500,000.
  • Convertible Loan proceeds will be used for advancing the bulk sample program on the Nine Mile Brook project and general working capital.
  • The terms of the Convertible Loan are subject to acceptance by the CSE.

Fusion Fuel Green Announces Strategic Tranched Financing from Belike Nominees Pty Ltd., a Macquarie Group Company

Retrieved on: 
Monday, November 27, 2023

Although subject to change, based on current market conditions, the initial tranche is not expected to be greater than 10% of the total Financing.

Key Points: 
  • Although subject to change, based on current market conditions, the initial tranche is not expected to be greater than 10% of the total Financing.
  • Until the conditions precedent as described herein are satisfied or waived, there can be no assurance that any portion of the Financing will be consummated.
  • Frederico Figueira de Chaves, CEO of Fusion Fuel, stated, “We are excited to enter into this agreement with Macquarie.
  • There can be no assurance that the Company will be able to complete the private placement on the terms described herein or at all.